Altesa BioSciences

College Park, GA · Founded 2020 · Privately Held (backing)

Developer of antiviral medicines designed for the treatment of respiratory infections and global viral threats. Altesa BioSciences is based in College Park, GA and was founded in 2020. It was valued at $190 million at its later-stage round in Feb 2026, the last priced event on record. It has raised $114 million across 2 recorded rounds; the latest was a $75 million later-stage round in Feb 2026.

PMV mark · valuation
$190.0M
Oct 2026
Priced at
its later-stage round
Feb 2026
Total raised
$114.0M
Last round
Later Stage VC
Feb 2026
How much has Altesa BioSciences raised?
$114.0Macross 2 recorded rounds · Dec 2022 – Feb 2026

Most recently, Altesa BioSciences raised $75.0M in its Later Stage VC (Feb 2026).

Free account
More of Altesa BioSciences with a free account
  • ·Watch Altesa BioSciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Altesa BioSciences round by round

2 rounds
Feb 2026Later Stage VC$75.0MSEC filing▮
17 investors participated
Dec 2022Early Stage VC$35.0MSEC filing▮
18 investors participated

How much has Altesa BioSciences raised?

Altesa BioSciences has raised $114 million across 2 recorded rounds since 2022. The largest was a $75 million later-stage round in Feb 2026.

Altesa BioSciences has filed 2 Form Ds with the SEC, most recently in Jul 2023 ($35 million sold to 18 investors).

Altesa BioSciences investors

7 investors are on record for Altesa BioSciences, including Pitango Venture Capital, Forbion, Atlantic Partners and GRA Venture Fund. The later-stage round in Feb 2026 drew 17 investors.

For fundraisers
Raising for a company like Altesa BioSciences?

7 investors have backed Altesa BioSciences.

See all 7 investors →

Frequently asked about Altesa BioSciences

How much has Altesa BioSciences raised?
Altesa BioSciences has raised $114.0M in total across 2 recorded funding rounds.
When was Altesa BioSciences's last funding round?
Altesa BioSciences's most recent recorded round was Later Stage VC in Feb 2026, raising $75.0M.